Lam Research Corp. 10-Q Summary: Quarter Ended March 26, 2000
Business Context and Reporting Period
Lam Research Corporation (Lam) manufactures semiconductor manufacturing equipment. This Form 10-Q covers the three and nine-month periods ended March 26, 2000. The company operates in a cyclical industry that experienced a significant recovery in late fiscal 1999, driven by increased demand for semiconductors and a migration to new materials like copper. Effective fiscal year 2000, Lam adopted a 52/53-week fiscal year ending on the last Sunday of June. On March 6, 2000, stockholders approved a three-for-one stock split and an increase in authorized shares to 400 million.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Mar 26, 2000 | 9 Months Ended Mar 26, 2000 |
|---|---|---|
| Total Revenue | $326,349 | $856,551 |
| Gross Margin | $144,986 (44.4%) | $371,473 (43.4%) |
| Operating Income | $76,041 | $143,020 |
| Net Income | $67,015 | $128,405 |
| Diluted EPS | $0.48 | $0.97 |
| Cash & Equivalents | $27,296 | $27,296 (Balance Sheet) |
| Short-term Investments | $294,182 | $294,182 (Balance Sheet) |
| Total Debt (Current + Long-term) | $330,701 | $330,701 (Balance Sheet) |
Note: Debt figures derived from Balance Sheet line items: Current portion of long-term debt ($7,644) + Long-term debt ($323,057).
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 113.3% for the quarter and 96.0% for the nine-month period compared to the prior year, driven by strong demand for the Alliance(TM) cluster system.
- Profitability Turnaround: The company reported a net income of $67.0 million for the quarter, a significant improvement from a net loss of $14.7 million in the same period of the prior year.
- Restructuring Reversal: A major factor in the improved results was a restructuring recovery (credit) of approximately $18.9 million. This resulted from the stronger-than-anticipated market recovery, allowing Lam to reoccupy vacated facilities, sell abandoned assets, and utilize previously written-off inventory.
- Margin Expansion: Gross margin percentage improved to 44.4% (quarter) and 43.4% (nine months) from 35.5% and 34.7% in the prior year, aided by cost reductions and the restructuring credit.
- Working Capital: Accounts receivable increased significantly to $306.7 million from $170.5 million, and inventories rose to $217.1 million from $183.7 million, reflecting higher sales volume.
Guidance, Outlook, and Risks
Outlook: Management anticipates the semiconductor industry upturn will continue through the end of calendar year 2000. Lam expects net revenue for the next quarter to be higher than the third quarter of fiscal 2000. Gross margins are expected to continue improving. The effective tax rate is estimated at 13% for fiscal 2000 but is expected to rise to approximately 30% in fiscal 2001.
Risks and Contingencies:
- Industry Volatility: Quarterly results are highly unpredictable due to the cyclical nature of the semiconductor industry and dependence on a limited number of high-priced systems.
- Product Concentration: A substantial percentage of revenue is derived from a limited number of products; failure to achieve market acceptance for new products (e.g., Teres(TM) and Exelan(TM)) poses a risk.
- Legal Proceedings: Lam is involved in patent infringement lawsuits with Varian Associates, Inc. and Tegal Corporation. While management does not believe these will have a material adverse effect, litigation outcomes are uncertain.
- System Transition: The company is transitioning to a new enterprise resource planning system, which carries risks of operational disruption.
- Derivatives: Lam holds call and put options on its own stock to offset dilution from convertible notes. Significant stock price declines could result in cash settlement obligations.
Investor Verification Checklist
- Restructuring Reversal Sustainability: Verify the specific components of the $18.9 million restructuring recovery to ensure it is not a recurring revenue stream.
- Order Backlog and Shipments: Confirm current order intake and shipment schedules to validate the expectation of higher revenue in the next quarter.
- Inventory Levels: Assess the $217 million inventory balance against current sales velocity to check for potential obsolescence risks if the market slows.
- Legal Exposure: Monitor the status of the Varian and Tegal patent lawsuits for any new developments or settlement discussions.
- Debt Covenants: Review the $100 million syndicated bank line of credit terms to ensure continued compliance with financial covenants.